Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-17

Clinical Trial Update: A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

View source ↗

Summary

Completed clinical trial evaluating Micardis (telmisartan) and Micardis Plus (telmisartan with hydrochlorothiazide) for controlling early morning blood pressure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)
  • Micardis Plus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED